[Retracted] Relationship between Prognosis, Immune Infiltration Level, and Differential Expression of PARVG Gene in Uterine Corpus Endometrial Carcinoma

Table 2

Association between PARVG expression and clinicopathologic variables using logistic regression.

Clinical characteristic	Total (N)	The odds ratio in PARVG expression
Age (continuous)	509	0.888 (0.628–1.258)	0.505
Stage (III vs IV)	139	0.351 (0.130–0.949)	0.039
Stage (I vs IV)	343	0.296 (0.114–0.765)	0.012
Stage (II vs IV)	75	0.321 (0.109–0.939)	0.038
Stage (I–III vs IV)	509	0.311 (0.121–0.796)	0.015